These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 2481664

  • 1. Augmentation of murine lymphokine-activated killer cell induction by a factor produced by Nocardia rubra cell wall skeleton-stimulated T cells.
    Kawase I, Shirasaka T, Ikeda T, Hara H, Tanio Y, Watanabe M, Saito S, Masuno T, Kishimoto S, Yamamura Y.
    Jpn J Cancer Res; 1989 Nov; 80(11):1098-105. PubMed ID: 2481664
    [Abstract] [Full Text] [Related]

  • 2. Synergy of Nocardia rubra cell wall skeleton and interleukin 2 in the in vivo induction of murine lymphokine-activated killer cell activity.
    Kawase I, Komuta K, Shirasaka T, Hara H, Tanio Y, Watanabe M, Saito S, Ikeda T, Masuno T, Kishimoto S.
    Jpn J Cancer Res; 1989 Nov; 80(11):1089-97. PubMed ID: 2514171
    [Abstract] [Full Text] [Related]

  • 3. Augmentative effect of Nocardia rubra cell-wall skeleton on the induction of human lymphokine-activated killer (LAK) cells by the production of LAK cell helper factor(s).
    Shirasaka T, Kawase I, Okada M, Kitahara M, Ikeda T, Komuta K, Hosoe S, Yokota S, Masuno T, Kishimoto S.
    Cancer Immunol Immunother; 1989 Nov; 30(4):195-204. PubMed ID: 2598189
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
    Mulé JJ, Krosnick JA, Rosenberg SA.
    J Immunol; 1989 Jan 15; 142(2):726-33. PubMed ID: 2783444
    [Abstract] [Full Text] [Related]

  • 7. Augmentative effect of Nocardia rubra cell-wall skeleton (N-CWS) on lymphokine-activated killer (LAK) cell induction.
    Yokota S, Shirasaka T, Nishikawa H, Hosoe S, Ikeda T, Komuta K, Kawase I, Masuno T, Ogura T, Kishimoto S.
    Cancer Immunol Immunother; 1988 Jan 15; 26(1):11-7. PubMed ID: 3257899
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interactive effects of alpha-interferon A/D and interleukin 2 on murine lymphokine-activated killer activity: analysis at the effector and precursor level.
    Chikkala NF, Lewis I, Ulchaker J, Stanley J, Tubbs R, Finke JH.
    Cancer Res; 1990 Feb 15; 50(4):1176-82. PubMed ID: 2297766
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prolongation of serum half-life of interleukin 2 and augmentation of lymphokine-activated killer cell activity by pepstatin in mice.
    Ohnishi H, Lin KM, Chu TM.
    Cancer Res; 1990 Feb 15; 50(4):1107-12. PubMed ID: 2297759
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Augmentation of murine lymphokine (rIL-2)-activated killer cell activity by indomethacin.
    Chao TY, Ohnishi H, Chu TM.
    Mol Biother; 1989 Feb 15; 1(6):318-22. PubMed ID: 2610950
    [Abstract] [Full Text] [Related]

  • 17. Augmentation of murine lymphokine-activated killer cell cytotoxicity by beta-cyclodextrin-benzaldehyde.
    Kuroki Y, Ochiai H, Kurokawa M, Niwayama S, Kishimoto C, Tazawa K, Fujimaki M.
    J Cancer Res Clin Oncol; 1991 Feb 15; 117(2):109-14. PubMed ID: 2007609
    [Abstract] [Full Text] [Related]

  • 18. Murine lymphokine-activated killer (LAK) cells: phenotypic characterization of the precursor and effector cells.
    Yang JC, Mulé JJ, Rosenberg SA.
    J Immunol; 1986 Jul 15; 137(2):715-22. PubMed ID: 2873187
    [Abstract] [Full Text] [Related]

  • 19. Lymphokine-activated effector cells: modulation of activity by cytokines.
    Mehta S, Flanagan P, Blackinton D, Wanebo H.
    Lymphokine Cytokine Res; 1992 Apr 15; 11(2):73-7. PubMed ID: 1581419
    [Abstract] [Full Text] [Related]

  • 20. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R, Suzuki S, Ebina N, Kumagai K.
    J Immunol; 1985 Apr 15; 134(4):2139-48. PubMed ID: 2579129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.